News

Novartis to start construction of new biotechnology facility in Singapore

Novartis announced the construction of a new state-of-the-art biotechnology production site in Singapore with an investment valued at over USD 500 million. The new facility will focus on drug substance manufacturing based on cell culture...

Antibiotic shows promise in treating extensively drug-resistant tuberculosis

When tested in patients hospitalized with extensively drug-resistant tuberculosis (XDR-TB) unresponsive to previous treatment, linezolid, an antibiotic used to treat severe bacterial infections, proved largely effective when added to the patients' ongoing TB treatment regimen. ...

New malaria drug requires just one dose and appears twice as effective as existing regimen

Scientists are reporting development of a new malaria drug that, in laboratory tests, has been twice as effective as the best current medicine against this global scourge and may fight off the disease with one dose, instead of...

Cold viruses point the way to new cancer therapies

Cold viruses generally get a bad rap - which they've certainly earned - but new findings by a team of scientists at the Salk Institute for Biological Studies suggest that these viruses might also be a valuable ally...

Target for obesity drugs comes into focus

Researchers at the University of Michigan have determined how the hormone leptin, an important regulator of metabolism and body weight, interacts with a key receptor in the brain. Leptin is a hormone secreted by fat...

Strategies proposed to improve impact of comparative effectiveness studies

Comparative effectiveness research conducted over the past decade has had a limited impact on the way medical care is delivered, but many opportunities exist to help doctors and others in the medical system translate such research into better...

UCB announces third research collaboration with Harvard University

UCB announced that it has launched a third collaborative research project with Harvard that builds upon the innovative Research Alliance they both signed in 2011. The third research project named 'Mining the Human Microbiome' will...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read